Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation: how to overcome the complement obstacle?

T E Mollnes1, A E Fiane

  • 1Department of Immunology and Transfusion Medicine, Nordland Central Hospital, University of Tromsø, Norway. tomeirik@fagmed.uit.no

Molecular Immunology
|July 14, 1999
PubMed
Summary

Xenotransplantation using pig organs faces hyperacute rejection due to human antibodies and complement. Genetic modification of pigs with human complement regulatory proteins shows promise for preventing this rejection in future clinical xenotransplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Scientific reports·2024
Same author

Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic Homeostasis.

Frontiers in immunology·2022
Same author

Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14.

Molecular immunology·2019
Same author

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Scientific reports·2019
Same author

Diffuse myocardial fibrosis in adolescents operated with arterial switch for transposition of the great arteries - A CMR study.

International journal of cardiology·2018
Same author

Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4.

Clinical and experimental immunology·2018

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Organ failure solutions

Background:

  • Shortage of human allografts and limitations of artificial organs drive xenotransplantation.
  • Pigs are the preferred donor species, but xenozoonoses, like pig endogenous retroviruses, pose risks.
  • Vascular xenografts face hyperacute rejection mediated by natural antibodies and complement.

Purpose of the Study:

  • To review hyperacute rejection in xenotransplantation.
  • To discuss methods for preventing hyperacute rejection, focusing on complement modulation.
  • To highlight the potential of transgenic pigs for clinical xenotransplantation.

Main Methods:

  • Review of existing literature on xenotransplantation and hyperacute rejection.

Related Experiment Videos

  • Discussion of complement regulatory mechanisms and their manipulation.
  • Analysis of recent studies on fluid-phase complement activation control.

    • Main Results:

    • Hyperacute rejection of vascular xenografts is a significant barrier.
    • Genetic modification of pigs with human complement regulatory proteins is a promising strategy.
    • Controlling fluid-phase complement activation is crucial for xenograft survival.

    Conclusions:

    • Transgenic pigs expressing human complement regulatory proteins offer a viable path for clinical xenotransplantation.
    • Effective modulation of the complement system is key to overcoming hyperacute rejection.
    • Further research into fluid-phase complement control is warranted for successful xenotransplantation.